News for 'drug development'

Infosys to acquire US-based Kaleidoscope Innovation

Infosys to acquire US-based Kaleidoscope Innovation

Rediff.com3 Sep 2020

It designs microsurgical instruments, devices used in minimally invasive surgery, drug delivery devices for ophthalmic therapies and user-centric wearables.

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Rediff.com10 Oct 2020

The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Saudi Arabia calls for dialogue between India and Pak

Saudi Arabia calls for dialogue between India and Pak

Rediff.com9 May 2021

The Crown Prince "welcomed the recent understanding reached between the military authorities of Pakistan and India regarding ceasefire at the Line of Control, which is based on a 2003 understanding between Pakistan and India.

Expert panel recommends granting emergency nod to Oxford vaccine

Expert panel recommends granting emergency nod to Oxford vaccine

Rediff.com2 Jan 2021

As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.

Cooperation must for regional security: Modi at Central Asia summit

Cooperation must for regional security: Modi at Central Asia summit

Rediff.com27 Jan 2022

India and five Central Asian countries on Thursday decided to establish a joint working group on Afghanistan at the senior officials' level, ministry of external affairs secretary (West) Reenat Sandhu said.

Phase 3 clinical trial of Oxford vaccine begins in Pune

Phase 3 clinical trial of Oxford vaccine begins in Pune

Rediff.com21 Sep 2020

"We have started the phase-III trials of the vaccine (candidate Covishield). We will administer dose to 150 to 200 volunteers," said Dr Muralidhar Tambe, Dean, Sassoon General Hospital.

Afghanistan must not become haven for terror, says Delhi declaration

Afghanistan must not become haven for terror, says Delhi declaration

Rediff.com10 Nov 2021

Top security czars of India, Russia, Iran and five central Asian countries on Wednesday pledged to work for ensuring that Afghanistan does not become a safe haven for global terrorism and called for the formation of an open and truly inclusive government in Kabul.

India may ease clinical trial norms for coronavirus vaccine

India may ease clinical trial norms for coronavirus vaccine

Rediff.com1 Apr 2020

The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.

Serum Inst gets DGCI notice over continuation of vaccine trial

Serum Inst gets DGCI notice over continuation of vaccine trial

Rediff.com9 Sep 2020

The show-cause notice was issued following reports that human trials of the most promising COVID-19 vaccine candidate, being developed by the University of Oxford, have been put on hold after a United Kingdom participant had an adverse reaction to it.

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Rediff.com14 Jun 2021

In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

Rediff.com3 Oct 2021

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its three-dose jab that can be given to those above 12 years of age.

3 sectors to watch for as economic growth picks up

3 sectors to watch for as economic growth picks up

Rediff.com12 Jan 2021

Overall, the credit profiles of players will be supported by healthy balance sheets and liquidity. Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22.

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Rediff.com12 May 2021

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

'Vigilant for every inch of land': Amit Shah on Ladakh row

'Vigilant for every inch of land': Amit Shah on Ladakh row

Rediff.com18 Oct 2020

The home minister also said that the government is committed to protecting the sovereignty and security of the country.

Serum Institute chief Adar Poonawalla takes Covishield jab

Serum Institute chief Adar Poonawalla takes Covishield jab

Rediff.com16 Jan 2021

Poonawalla wished the country and Prime Minister Narendra Modi success for the vaccination programme.

China rolls out first one-jab COVID-19 vaccine: Report

China rolls out first one-jab COVID-19 vaccine: Report

Rediff.com28 Feb 2021

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.

Lankan presidential secretariat reopens after blockade; 3 held for theft

Lankan presidential secretariat reopens after blockade; 3 held for theft

Rediff.com25 Jul 2022

The presidential secretariat which was occupied by the protesters from July 9 till Friday last is re-opened and the staff reported to work on Monday, officials said.

Shinde govt comes under fire as another project moves to Gujarat

Shinde govt comes under fire as another project moves to Gujarat

Rediff.com28 Oct 2022

The Eknath Shinde-led Maharashtra government has come under fire following the Centre's announcement that Tata-Airbus C-295 transport aircraft project would be set up in Gujarat, with the opposition seeking to know why the project that was supposed to come up in Maharashtra went to the neighbouring state.

What Capt Amarinder Singh told Sonia Gandhi before quitting as CM

What Capt Amarinder Singh told Sonia Gandhi before quitting as CM

Rediff.com19 Sep 2021

"Notwithstanding my personal anguish, I hope this will not cause any damage to the hard-earned peace and development in the state," Singh wrote in his letter to Gandhi

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Rediff.com17 Aug 2022

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.'

10 things to know about COVID-19 vaccines

10 things to know about COVID-19 vaccines

Rediff.com16 Jan 2021

As India holds its breath for the Covid vaccination to be begin, Sudhir Bisht provides a quick checklist of what you must know about the vaccines that will be administered to citizens.

Want to invest in Healthcare ETFs?

Want to invest in Healthcare ETFs?

Rediff.com4 Jun 2021

If a retail investor wants exposure to a healthcare ETF, it should be a part of his satellite portfolio, suggests Sanjay Kumar Singh.

8 nations call for joint efforts to deal terrorism from Afghanistan

8 nations call for joint efforts to deal terrorism from Afghanistan

Rediff.com10 Nov 2021

Doval said it is time for closer consultations, greater cooperation and coordination among the regional countries to deal with the challenges emanating from Afghanistan.

Modi releases Namibian cheetahs in MP's Kuno National Park

Modi releases Namibian cheetahs in MP's Kuno National Park

Rediff.com17 Sep 2022

Seven decades after they became extinct in India, eight Cheetahs arrived in the country from Namibia by a special flight on Saturday morning and were released by Prime Minister Narendra Modi in Madhya Pradesh's Kuno National Park (KNP).

Hydroxychloroquine may cause heartbeat disturbances: Study

Hydroxychloroquine may cause heartbeat disturbances: Study

Rediff.com2 Jun 2020

In the study, the scientists assessed the effects of the drug in two types of animal hearts, and found that it altered the timing of electrical waves that control heartbeat.

Uncertain future awaits Indian pharma exporters

Uncertain future awaits Indian pharma exporters

Rediff.com25 Aug 2021

As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country and the target of exporting $126 million worth of pharmaceutical goods to the Taliban-ruling nation now depends on the future outcome. Udaya Bhaskar, director general of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as the situation is grim over there and India pharma exporters have cordial relations with Afghanistan. "The projected target for 2021-22 is $126.22 million.

Danger of terror spreading into Russia, India from Af: Russian Envoy

Danger of terror spreading into Russia, India from Af: Russian Envoy

Rediff.com6 Sep 2021

Delving into implications of the latest developments in Afghanistan, Russian Ambassador Nikolay Kudashev said that there is a danger of the possible spread of terror into Russian territory as well as Kashmir, noting that India and Russia will continue to work together to counter any threat of terrorism.

India approves Oxford's, Bharat Biotech's vaccines for emergency use

India approves Oxford's, Bharat Biotech's vaccines for emergency use

Rediff.com3 Jan 2021

The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

COVID-19 vaccine Covaxin enters phase-3 trials

COVID-19 vaccine Covaxin enters phase-3 trials

Rediff.com16 Nov 2020

Covaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research - National Institute of Virology.

Patanjali can sell Coronil but not as cure to COVID-19: AYUSH

Patanjali can sell Coronil but not as cure to COVID-19: AYUSH

Rediff.com1 Jul 2020

The company claimed that the AYUSH ministry has "categorically agreed" that Patanjali had "appropriately worked on COVID-19 management".

Why China won't attend NSA-level meet on Afghanistan hosted by India

Why China won't attend NSA-level meet on Afghanistan hosted by India

Rediff.com9 Nov 2021

"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

Rediff.com10 Jan 2023

This doctor couple put their faith in India. And in return India has put faith in them.

'Nawab Malik has been jailed to keep him quiet'

'Nawab Malik has been jailed to keep him quiet'

Rediff.com28 Mar 2022

'After he had exposed the Narcotics Bureau's wrongdoings, he threatened to expose the Enforcement Directorate as well.' 'So they are trying to rake up an old legal deal, distorting information and using the PMLA which did not even exist at that time.'

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

Expert panel seeks more data on SII, Bharat Biotech vaccines

Expert panel seeks more data on SII, Bharat Biotech vaccines

Rediff.com10 Dec 2020

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.

Always hungry? Blame your brain

Always hungry? Blame your brain

Rediff.com6 Jun 2018

The brain's hunger centre has a way of communicating signals that cause you to overeat.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

Will probe 'ISI links' of Amarinder's friend: Punjab deputy CM

Will probe 'ISI links' of Amarinder's friend: Punjab deputy CM

Rediff.com23 Oct 2021

Punjab's Deputy Chief Minister Sukhjinder Singh Randhawa has said a probe would be carried out to ascertain whether Aroosa Alam, a Pakistani journalist who has been visiting former chief minister Amarinder Singh for several years, has links with the ISI.

Maneka Gandhi suggests legalising marijuana for medical purposes

Maneka Gandhi suggests legalising marijuana for medical purposes

Rediff.com30 Jul 2017

She also suggested exploring the possibility of setting up de-addiction centres near these railway stations.